Digital Solutions for Reliable Endpoints
We Have Solutions to Help Your Study Succeed
As part of our eCOA solution, the IBD Diary collects patient-reported outcomes through an easy-to-use, electronic format to encourage daily completion and improve data quality.
Enhance Primary Endpoints
Calculate Accurate Scores
Signant’s eCOA solution can complete the required scoring calculations, eliminating the risk of manual errors and the need for another integrated system.
Gain Expert Guidance
Signant’s scientific and clinical experts will help you navigate common study challenges such as identifying key data points and ensuring that complex scores are calculated correctly.
Improve Patient Engagement
Patient Concierge promotes communication between the site and patient, which can make patients feel more involved in the overall process.
Simplify Participation
Virtually recreating the clinic experience, our Telemedicine reduces the number of in-person visits needed and offers flexibility to complete study assessments.
Digitalize the Entire Study
All the Signant SmartSignals solutions can be used as standalone tools or integrated with one another to further enhance the accuracy and efficiency of your IBD study.
100
LANGUAGES
COUNTRIES
59
87,000+
PATIENTS
34,000+
SITES
STUDIES
266
I - IV
PHASES
Our Gastroenterology Experience by the Numbers
IBD Solutions
IBD Trial Solution Resources
Signant's Subject Matter Experts
IBD Trial Solutions
Enhance Your IBD Clinical Trials with Signant
TELEMEDICINE
PATIENT CONCIERGE
eCOA
LEARN MORE 🠖LEARN MORE 🠖LEARN MORE 🠖
READY TO GET STARTED?
See how Signant can support your next IBD clinical trial.
Over one million people suffer from Inflammatory bowel disease (IBD) in the US alone. Researchers today are working to improve quality of life for IBD patients with treatments that make the chronic, life-long condition more manageable. Clinical trials that accurately collect patient-reported outcomes and calculate symptom scores contribute to this effort.
